EXCLI Journal-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=924497, encodeId=285c92449e11, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2018年底投了一篇，1周左右接收，1个月内proof完，接着1个月左右就收录了。不收费。2021年2月再投一篇，结果1周拒了，说是投稿量大，要控制质量，连外审也没送……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDXbgYEwSHiaocLMqOYLBtz9vM1U37Snr4nGLkM2T0V42MoT2hzovDnwNtXw6hdydkhYK3JHnibichHg/0, createdBy=fda41688247, createdName=懒懒的, createdTime=Sat Feb 13 23:29:25 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249235, encodeId=4ec612492356a, content=纯生信收不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b468322691, createdName=ms4000000003909945, createdTime=Thu Sep 15 23:44:27 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101622, encodeId=828411016222f, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101621, encodeId=6968110162159, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590947, encodeId=ef2359094e33, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：***, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590948, encodeId=2e6959094804, content=1.综合性期刊从期刊名就可以看出，该期刊主要收录的研究范围是包括了所有的 experimental 和 clinical 研究的。所以，生物学、医学等生命科学领域的很多文章都可以往这里投。 2.是OA但不收费这种情况是学术界是很少见的，此前还说过一个国产杂志Asian Journal of Pharmaceutical Sciences，也是这样（OA杂志就一定要作者掏钱吗？），但是国产SCI期刊经常会有走后门的文章，一般很难投中。这个杂志似乎更加公平得多。 3.关注者少/竞争小从MedSci投稿经验分享里面可以看出来，其关注人数很少。起的这么诡异的一个期刊名，恐怕是导致其很少被人关注的一个重要原因。 4.审稿快/见刊快一般一审大约2-4周，不拖沓。虽然一年只有一期，但是基本都是接收后很快就上线，紧接着就是WOS收录，并不是等所有文章都准备好了再作为一期统一在线发表。随机查阅几篇今年的文献可以发现，接收的文章一般1-3个月接收，1个月左右发表，赶巧的话，一周内就发表了。 e.g. Received: February 25, 2019, accepted: April 25, 2019, published: May 21, 2019 Received: November 15, 2018, accepted: March 18, 2019, published: March 22, 2019 Received: September 21, 2018, accepted: December 12, 2018, published: January 24, 2019 Received: October 26, 2017, accepted: January 12, 2018, published: January 23, 2019 Received: April 16, 2019, accepted: May 02, 2019, published: May 28, 2019 5.缺点无投稿系统，通过邮箱投稿，无法查询稿件状态，需要通过邮件询问，但是邮件回复的速度很快。不过，目前该杂志已经在着手建立网上投稿系统了，是否可用另一个重要的缺点就是经常要求提交所有的原始数据给杂志社，比较麻烦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541727, encodeId=4f8a541e27d2, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493327, encodeId=3fe449332ef9, content=最好别投这个期刊，现在审稿速度慢，而且要求高，容易拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jan 07 17:02:00 CST 2013, time=2013-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491547, encodeId=743049154e8b, content=听说这个期刊审稿很快。有没有人投稿成功的？分享一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 20 16:28:00 CST 2012, time=2012-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488881, encodeId=8e8d488881b8, content=似乎一年才出一期，20-30篇文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=tjuzhni, createdTime=Tue Jun 12 11:33:00 CST 2012, time=2012-06-12, status=1, ipAttribution=)]

2021-02-13 懒懒的

审稿速度:1.0 | 投稿命中率:75.0
经验分享：2018年底投了一篇，1周左右接收，1个月内proof完，接着1个月左右就收录了。不收费。2021年2月再投一篇，结果1周拒了，说是投稿量大，要控制质量，连外审也没送……

171 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=924497, encodeId=285c92449e11, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2018年底投了一篇，1周左右接收，1个月内proof完，接着1个月左右就收录了。不收费。2021年2月再投一篇，结果1周拒了，说是投稿量大，要控制质量，连外审也没送……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDXbgYEwSHiaocLMqOYLBtz9vM1U37Snr4nGLkM2T0V42MoT2hzovDnwNtXw6hdydkhYK3JHnibichHg/0, createdBy=fda41688247, createdName=懒懒的, createdTime=Sat Feb 13 23:29:25 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249235, encodeId=4ec612492356a, content=纯生信收不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b468322691, createdName=ms4000000003909945, createdTime=Thu Sep 15 23:44:27 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101622, encodeId=828411016222f, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101621, encodeId=6968110162159, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590947, encodeId=ef2359094e33, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：***, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590948, encodeId=2e6959094804, content=1.综合性期刊从期刊名就可以看出，该期刊主要收录的研究范围是包括了所有的 experimental 和 clinical 研究的。所以，生物学、医学等生命科学领域的很多文章都可以往这里投。 2.是OA但不收费这种情况是学术界是很少见的，此前还说过一个国产杂志Asian Journal of Pharmaceutical Sciences，也是这样（OA杂志就一定要作者掏钱吗？），但是国产SCI期刊经常会有走后门的文章，一般很难投中。这个杂志似乎更加公平得多。 3.关注者少/竞争小从MedSci投稿经验分享里面可以看出来，其关注人数很少。起的这么诡异的一个期刊名，恐怕是导致其很少被人关注的一个重要原因。 4.审稿快/见刊快一般一审大约2-4周，不拖沓。虽然一年只有一期，但是基本都是接收后很快就上线，紧接着就是WOS收录，并不是等所有文章都准备好了再作为一期统一在线发表。随机查阅几篇今年的文献可以发现，接收的文章一般1-3个月接收，1个月左右发表，赶巧的话，一周内就发表了。 e.g. Received: February 25, 2019, accepted: April 25, 2019, published: May 21, 2019 Received: November 15, 2018, accepted: March 18, 2019, published: March 22, 2019 Received: September 21, 2018, accepted: December 12, 2018, published: January 24, 2019 Received: October 26, 2017, accepted: January 12, 2018, published: January 23, 2019 Received: April 16, 2019, accepted: May 02, 2019, published: May 28, 2019 5.缺点无投稿系统，通过邮箱投稿，无法查询稿件状态，需要通过邮件询问，但是邮件回复的速度很快。不过，目前该杂志已经在着手建立网上投稿系统了，是否可用另一个重要的缺点就是经常要求提交所有的原始数据给杂志社，比较麻烦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541727, encodeId=4f8a541e27d2, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493327, encodeId=3fe449332ef9, content=最好别投这个期刊，现在审稿速度慢，而且要求高，容易拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jan 07 17:02:00 CST 2013, time=2013-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491547, encodeId=743049154e8b, content=听说这个期刊审稿很快。有没有人投稿成功的？分享一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 20 16:28:00 CST 2012, time=2012-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488881, encodeId=8e8d488881b8, content=似乎一年才出一期，20-30篇文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=tjuzhni, createdTime=Tue Jun 12 11:33:00 CST 2012, time=2012-06-12, status=1, ipAttribution=)]

2022-09-15 ms4000000003909945

纯生信收不?

86 0

[GetPortalCommentsPageByObjectIdResponse(id=924497, encodeId=285c92449e11, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2018年底投了一篇，1周左右接收，1个月内proof完，接着1个月左右就收录了。不收费。2021年2月再投一篇，结果1周拒了，说是投稿量大，要控制质量，连外审也没送……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDXbgYEwSHiaocLMqOYLBtz9vM1U37Snr4nGLkM2T0V42MoT2hzovDnwNtXw6hdydkhYK3JHnibichHg/0, createdBy=fda41688247, createdName=懒懒的, createdTime=Sat Feb 13 23:29:25 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249235, encodeId=4ec612492356a, content=纯生信收不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b468322691, createdName=ms4000000003909945, createdTime=Thu Sep 15 23:44:27 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101622, encodeId=828411016222f, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101621, encodeId=6968110162159, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590947, encodeId=ef2359094e33, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：***, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590948, encodeId=2e6959094804, content=1.综合性期刊从期刊名就可以看出，该期刊主要收录的研究范围是包括了所有的 experimental 和 clinical 研究的。所以，生物学、医学等生命科学领域的很多文章都可以往这里投。 2.是OA但不收费这种情况是学术界是很少见的，此前还说过一个国产杂志Asian Journal of Pharmaceutical Sciences，也是这样（OA杂志就一定要作者掏钱吗？），但是国产SCI期刊经常会有走后门的文章，一般很难投中。这个杂志似乎更加公平得多。 3.关注者少/竞争小从MedSci投稿经验分享里面可以看出来，其关注人数很少。起的这么诡异的一个期刊名，恐怕是导致其很少被人关注的一个重要原因。 4.审稿快/见刊快一般一审大约2-4周，不拖沓。虽然一年只有一期，但是基本都是接收后很快就上线，紧接着就是WOS收录，并不是等所有文章都准备好了再作为一期统一在线发表。随机查阅几篇今年的文献可以发现，接收的文章一般1-3个月接收，1个月左右发表，赶巧的话，一周内就发表了。 e.g. Received: February 25, 2019, accepted: April 25, 2019, published: May 21, 2019 Received: November 15, 2018, accepted: March 18, 2019, published: March 22, 2019 Received: September 21, 2018, accepted: December 12, 2018, published: January 24, 2019 Received: October 26, 2017, accepted: January 12, 2018, published: January 23, 2019 Received: April 16, 2019, accepted: May 02, 2019, published: May 28, 2019 5.缺点无投稿系统，通过邮箱投稿，无法查询稿件状态，需要通过邮件询问，但是邮件回复的速度很快。不过，目前该杂志已经在着手建立网上投稿系统了，是否可用另一个重要的缺点就是经常要求提交所有的原始数据给杂志社，比较麻烦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541727, encodeId=4f8a541e27d2, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493327, encodeId=3fe449332ef9, content=最好别投这个期刊，现在审稿速度慢，而且要求高，容易拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jan 07 17:02:00 CST 2013, time=2013-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491547, encodeId=743049154e8b, content=听说这个期刊审稿很快。有没有人投稿成功的？分享一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 20 16:28:00 CST 2012, time=2012-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488881, encodeId=8e8d488881b8, content=似乎一年才出一期，20-30篇文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=tjuzhni, createdTime=Tue Jun 12 11:33:00 CST 2012, time=2012-06-12, status=1, ipAttribution=)]

2021-12-29 Mia

两个IF相当的期刊，如何选择要投哪个？

88 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=924497, encodeId=285c92449e11, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2018年底投了一篇，1周左右接收，1个月内proof完，接着1个月左右就收录了。不收费。2021年2月再投一篇，结果1周拒了，说是投稿量大，要控制质量，连外审也没送……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDXbgYEwSHiaocLMqOYLBtz9vM1U37Snr4nGLkM2T0V42MoT2hzovDnwNtXw6hdydkhYK3JHnibichHg/0, createdBy=fda41688247, createdName=懒懒的, createdTime=Sat Feb 13 23:29:25 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249235, encodeId=4ec612492356a, content=纯生信收不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b468322691, createdName=ms4000000003909945, createdTime=Thu Sep 15 23:44:27 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101622, encodeId=828411016222f, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101621, encodeId=6968110162159, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590947, encodeId=ef2359094e33, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：***, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590948, encodeId=2e6959094804, content=1.综合性期刊从期刊名就可以看出，该期刊主要收录的研究范围是包括了所有的 experimental 和 clinical 研究的。所以，生物学、医学等生命科学领域的很多文章都可以往这里投。 2.是OA但不收费这种情况是学术界是很少见的，此前还说过一个国产杂志Asian Journal of Pharmaceutical Sciences，也是这样（OA杂志就一定要作者掏钱吗？），但是国产SCI期刊经常会有走后门的文章，一般很难投中。这个杂志似乎更加公平得多。 3.关注者少/竞争小从MedSci投稿经验分享里面可以看出来，其关注人数很少。起的这么诡异的一个期刊名，恐怕是导致其很少被人关注的一个重要原因。 4.审稿快/见刊快一般一审大约2-4周，不拖沓。虽然一年只有一期，但是基本都是接收后很快就上线，紧接着就是WOS收录，并不是等所有文章都准备好了再作为一期统一在线发表。随机查阅几篇今年的文献可以发现，接收的文章一般1-3个月接收，1个月左右发表，赶巧的话，一周内就发表了。 e.g. Received: February 25, 2019, accepted: April 25, 2019, published: May 21, 2019 Received: November 15, 2018, accepted: March 18, 2019, published: March 22, 2019 Received: September 21, 2018, accepted: December 12, 2018, published: January 24, 2019 Received: October 26, 2017, accepted: January 12, 2018, published: January 23, 2019 Received: April 16, 2019, accepted: May 02, 2019, published: May 28, 2019 5.缺点无投稿系统，通过邮箱投稿，无法查询稿件状态，需要通过邮件询问，但是邮件回复的速度很快。不过，目前该杂志已经在着手建立网上投稿系统了，是否可用另一个重要的缺点就是经常要求提交所有的原始数据给杂志社，比较麻烦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541727, encodeId=4f8a541e27d2, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493327, encodeId=3fe449332ef9, content=最好别投这个期刊，现在审稿速度慢，而且要求高，容易拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jan 07 17:02:00 CST 2013, time=2013-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491547, encodeId=743049154e8b, content=听说这个期刊审稿很快。有没有人投稿成功的？分享一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 20 16:28:00 CST 2012, time=2012-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488881, encodeId=8e8d488881b8, content=似乎一年才出一期，20-30篇文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=tjuzhni, createdTime=Tue Jun 12 11:33:00 CST 2012, time=2012-06-12, status=1, ipAttribution=)]

2021-12-28 MS68862005

老牌期刊和新出版期刊是否都要选一些？

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=924497, encodeId=285c92449e11, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2018年底投了一篇，1周左右接收，1个月内proof完，接着1个月左右就收录了。不收费。2021年2月再投一篇，结果1周拒了，说是投稿量大，要控制质量，连外审也没送……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDXbgYEwSHiaocLMqOYLBtz9vM1U37Snr4nGLkM2T0V42MoT2hzovDnwNtXw6hdydkhYK3JHnibichHg/0, createdBy=fda41688247, createdName=懒懒的, createdTime=Sat Feb 13 23:29:25 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249235, encodeId=4ec612492356a, content=纯生信收不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b468322691, createdName=ms4000000003909945, createdTime=Thu Sep 15 23:44:27 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101622, encodeId=828411016222f, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101621, encodeId=6968110162159, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590947, encodeId=ef2359094e33, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：***, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590948, encodeId=2e6959094804, content=1.综合性期刊从期刊名就可以看出，该期刊主要收录的研究范围是包括了所有的 experimental 和 clinical 研究的。所以，生物学、医学等生命科学领域的很多文章都可以往这里投。 2.是OA但不收费这种情况是学术界是很少见的，此前还说过一个国产杂志Asian Journal of Pharmaceutical Sciences，也是这样（OA杂志就一定要作者掏钱吗？），但是国产SCI期刊经常会有走后门的文章，一般很难投中。这个杂志似乎更加公平得多。 3.关注者少/竞争小从MedSci投稿经验分享里面可以看出来，其关注人数很少。起的这么诡异的一个期刊名，恐怕是导致其很少被人关注的一个重要原因。 4.审稿快/见刊快一般一审大约2-4周，不拖沓。虽然一年只有一期，但是基本都是接收后很快就上线，紧接着就是WOS收录，并不是等所有文章都准备好了再作为一期统一在线发表。随机查阅几篇今年的文献可以发现，接收的文章一般1-3个月接收，1个月左右发表，赶巧的话，一周内就发表了。 e.g. Received: February 25, 2019, accepted: April 25, 2019, published: May 21, 2019 Received: November 15, 2018, accepted: March 18, 2019, published: March 22, 2019 Received: September 21, 2018, accepted: December 12, 2018, published: January 24, 2019 Received: October 26, 2017, accepted: January 12, 2018, published: January 23, 2019 Received: April 16, 2019, accepted: May 02, 2019, published: May 28, 2019 5.缺点无投稿系统，通过邮箱投稿，无法查询稿件状态，需要通过邮件询问，但是邮件回复的速度很快。不过，目前该杂志已经在着手建立网上投稿系统了，是否可用另一个重要的缺点就是经常要求提交所有的原始数据给杂志社，比较麻烦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541727, encodeId=4f8a541e27d2, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493327, encodeId=3fe449332ef9, content=最好别投这个期刊，现在审稿速度慢，而且要求高，容易拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jan 07 17:02:00 CST 2013, time=2013-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491547, encodeId=743049154e8b, content=听说这个期刊审稿很快。有没有人投稿成功的？分享一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 20 16:28:00 CST 2012, time=2012-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488881, encodeId=8e8d488881b8, content=似乎一年才出一期，20-30篇文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=tjuzhni, createdTime=Tue Jun 12 11:33:00 CST 2012, time=2012-06-12, status=1, ipAttribution=)]

2020-05-15 lovetcm

审稿速度:1.0 | 投稿命中率:75.0
经验分享：***

145 0

[GetPortalCommentsPageByObjectIdResponse(id=924497, encodeId=285c92449e11, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2018年底投了一篇，1周左右接收，1个月内proof完，接着1个月左右就收录了。不收费。2021年2月再投一篇，结果1周拒了，说是投稿量大，要控制质量，连外审也没送……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDXbgYEwSHiaocLMqOYLBtz9vM1U37Snr4nGLkM2T0V42MoT2hzovDnwNtXw6hdydkhYK3JHnibichHg/0, createdBy=fda41688247, createdName=懒懒的, createdTime=Sat Feb 13 23:29:25 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249235, encodeId=4ec612492356a, content=纯生信收不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b468322691, createdName=ms4000000003909945, createdTime=Thu Sep 15 23:44:27 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101622, encodeId=828411016222f, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101621, encodeId=6968110162159, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590947, encodeId=ef2359094e33, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：***, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590948, encodeId=2e6959094804, content=1.综合性期刊从期刊名就可以看出，该期刊主要收录的研究范围是包括了所有的 experimental 和 clinical 研究的。所以，生物学、医学等生命科学领域的很多文章都可以往这里投。 2.是OA但不收费这种情况是学术界是很少见的，此前还说过一个国产杂志Asian Journal of Pharmaceutical Sciences，也是这样（OA杂志就一定要作者掏钱吗？），但是国产SCI期刊经常会有走后门的文章，一般很难投中。这个杂志似乎更加公平得多。 3.关注者少/竞争小从MedSci投稿经验分享里面可以看出来，其关注人数很少。起的这么诡异的一个期刊名，恐怕是导致其很少被人关注的一个重要原因。 4.审稿快/见刊快一般一审大约2-4周，不拖沓。虽然一年只有一期，但是基本都是接收后很快就上线，紧接着就是WOS收录，并不是等所有文章都准备好了再作为一期统一在线发表。随机查阅几篇今年的文献可以发现，接收的文章一般1-3个月接收，1个月左右发表，赶巧的话，一周内就发表了。 e.g. Received: February 25, 2019, accepted: April 25, 2019, published: May 21, 2019 Received: November 15, 2018, accepted: March 18, 2019, published: March 22, 2019 Received: September 21, 2018, accepted: December 12, 2018, published: January 24, 2019 Received: October 26, 2017, accepted: January 12, 2018, published: January 23, 2019 Received: April 16, 2019, accepted: May 02, 2019, published: May 28, 2019 5.缺点无投稿系统，通过邮箱投稿，无法查询稿件状态，需要通过邮件询问，但是邮件回复的速度很快。不过，目前该杂志已经在着手建立网上投稿系统了，是否可用另一个重要的缺点就是经常要求提交所有的原始数据给杂志社，比较麻烦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541727, encodeId=4f8a541e27d2, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493327, encodeId=3fe449332ef9, content=最好别投这个期刊，现在审稿速度慢，而且要求高，容易拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jan 07 17:02:00 CST 2013, time=2013-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491547, encodeId=743049154e8b, content=听说这个期刊审稿很快。有没有人投稿成功的？分享一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 20 16:28:00 CST 2012, time=2012-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488881, encodeId=8e8d488881b8, content=似乎一年才出一期，20-30篇文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=tjuzhni, createdTime=Tue Jun 12 11:33:00 CST 2012, time=2012-06-12, status=1, ipAttribution=)]

2020-05-15 lovetcm

1.综合性期刊从期刊名就可以看出，该期刊主要收录的研究范围是包括了所有的 experimental 和 clinical 研究的。所以，生物学、医学等生命科学领域的很多文章都可以往这里投。 2.是OA但不收费这种情况是学术界是很少见的，此前还说过一个国产杂志Asian Journal of Pharmaceutical Sciences，也是这样（OA杂志就一定要作者掏钱吗？），但是国产SCI期刊经常会有走后门的文章，一般很难投中。这个杂志似乎更加公平得多。 3.关注者少/竞争小从MedSci投稿经验分享里面可以看出来，其关注人数很少。起的这么诡异的一个期刊名，恐怕是导致其很少被人关注的一个重要原因。 4.审稿快/见刊快一般一审大约2-4周，不拖沓。虽然一年只有一期，但是基本都是接收后很快就上线，紧接着就是WOS收录，并不是等所有文章都准备好了再作为一期统一在线发表。随机查阅几篇今年的文献可以发现，接收的文章一般1-3个月接收，1个月左右发表，赶巧的话，一周内就发表了。 e.g. Received: February 25, 2019, accepted: April 25, 2019, published: May 21, 2019 Received: November 15, 2018, accepted: March 18, 2019, published: March 22, 2019 Received: September 21, 2018, accepted: December 12, 2018, published: January 24, 2019 Received: October 26, 2017, accepted: January 12, 2018, published: January 23, 2019 Received: April 16, 2019, accepted: May 02, 2019, published: May 28, 2019 5.缺点无投稿系统，通过邮箱投稿，无法查询稿件状态，需要通过邮件询问，但是邮件回复的速度很快。不过，目前该杂志已经在着手建立网上投稿系统了，是否可用另一个重要的缺点就是经常要求提交所有的原始数据给杂志社，比较麻烦。

145 0

[GetPortalCommentsPageByObjectIdResponse(id=924497, encodeId=285c92449e11, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2018年底投了一篇，1周左右接收，1个月内proof完，接着1个月左右就收录了。不收费。2021年2月再投一篇，结果1周拒了，说是投稿量大，要控制质量，连外审也没送……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDXbgYEwSHiaocLMqOYLBtz9vM1U37Snr4nGLkM2T0V42MoT2hzovDnwNtXw6hdydkhYK3JHnibichHg/0, createdBy=fda41688247, createdName=懒懒的, createdTime=Sat Feb 13 23:29:25 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249235, encodeId=4ec612492356a, content=纯生信收不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b468322691, createdName=ms4000000003909945, createdTime=Thu Sep 15 23:44:27 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101622, encodeId=828411016222f, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101621, encodeId=6968110162159, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590947, encodeId=ef2359094e33, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：***, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590948, encodeId=2e6959094804, content=1.综合性期刊从期刊名就可以看出，该期刊主要收录的研究范围是包括了所有的 experimental 和 clinical 研究的。所以，生物学、医学等生命科学领域的很多文章都可以往这里投。 2.是OA但不收费这种情况是学术界是很少见的，此前还说过一个国产杂志Asian Journal of Pharmaceutical Sciences，也是这样（OA杂志就一定要作者掏钱吗？），但是国产SCI期刊经常会有走后门的文章，一般很难投中。这个杂志似乎更加公平得多。 3.关注者少/竞争小从MedSci投稿经验分享里面可以看出来，其关注人数很少。起的这么诡异的一个期刊名，恐怕是导致其很少被人关注的一个重要原因。 4.审稿快/见刊快一般一审大约2-4周，不拖沓。虽然一年只有一期，但是基本都是接收后很快就上线，紧接着就是WOS收录，并不是等所有文章都准备好了再作为一期统一在线发表。随机查阅几篇今年的文献可以发现，接收的文章一般1-3个月接收，1个月左右发表，赶巧的话，一周内就发表了。 e.g. Received: February 25, 2019, accepted: April 25, 2019, published: May 21, 2019 Received: November 15, 2018, accepted: March 18, 2019, published: March 22, 2019 Received: September 21, 2018, accepted: December 12, 2018, published: January 24, 2019 Received: October 26, 2017, accepted: January 12, 2018, published: January 23, 2019 Received: April 16, 2019, accepted: May 02, 2019, published: May 28, 2019 5.缺点无投稿系统，通过邮箱投稿，无法查询稿件状态，需要通过邮件询问，但是邮件回复的速度很快。不过，目前该杂志已经在着手建立网上投稿系统了，是否可用另一个重要的缺点就是经常要求提交所有的原始数据给杂志社，比较麻烦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541727, encodeId=4f8a541e27d2, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493327, encodeId=3fe449332ef9, content=最好别投这个期刊，现在审稿速度慢，而且要求高，容易拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jan 07 17:02:00 CST 2013, time=2013-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491547, encodeId=743049154e8b, content=听说这个期刊审稿很快。有没有人投稿成功的？分享一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 20 16:28:00 CST 2012, time=2012-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488881, encodeId=8e8d488881b8, content=似乎一年才出一期，20-30篇文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=tjuzhni, createdTime=Tue Jun 12 11:33:00 CST 2012, time=2012-06-12, status=1, ipAttribution=)]

2017-07-14 huabing

马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了

332 0

[GetPortalCommentsPageByObjectIdResponse(id=924497, encodeId=285c92449e11, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2018年底投了一篇，1周左右接收，1个月内proof完，接着1个月左右就收录了。不收费。2021年2月再投一篇，结果1周拒了，说是投稿量大，要控制质量，连外审也没送……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDXbgYEwSHiaocLMqOYLBtz9vM1U37Snr4nGLkM2T0V42MoT2hzovDnwNtXw6hdydkhYK3JHnibichHg/0, createdBy=fda41688247, createdName=懒懒的, createdTime=Sat Feb 13 23:29:25 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249235, encodeId=4ec612492356a, content=纯生信收不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b468322691, createdName=ms4000000003909945, createdTime=Thu Sep 15 23:44:27 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101622, encodeId=828411016222f, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101621, encodeId=6968110162159, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590947, encodeId=ef2359094e33, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：***, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590948, encodeId=2e6959094804, content=1.综合性期刊从期刊名就可以看出，该期刊主要收录的研究范围是包括了所有的 experimental 和 clinical 研究的。所以，生物学、医学等生命科学领域的很多文章都可以往这里投。 2.是OA但不收费这种情况是学术界是很少见的，此前还说过一个国产杂志Asian Journal of Pharmaceutical Sciences，也是这样（OA杂志就一定要作者掏钱吗？），但是国产SCI期刊经常会有走后门的文章，一般很难投中。这个杂志似乎更加公平得多。 3.关注者少/竞争小从MedSci投稿经验分享里面可以看出来，其关注人数很少。起的这么诡异的一个期刊名，恐怕是导致其很少被人关注的一个重要原因。 4.审稿快/见刊快一般一审大约2-4周，不拖沓。虽然一年只有一期，但是基本都是接收后很快就上线，紧接着就是WOS收录，并不是等所有文章都准备好了再作为一期统一在线发表。随机查阅几篇今年的文献可以发现，接收的文章一般1-3个月接收，1个月左右发表，赶巧的话，一周内就发表了。 e.g. Received: February 25, 2019, accepted: April 25, 2019, published: May 21, 2019 Received: November 15, 2018, accepted: March 18, 2019, published: March 22, 2019 Received: September 21, 2018, accepted: December 12, 2018, published: January 24, 2019 Received: October 26, 2017, accepted: January 12, 2018, published: January 23, 2019 Received: April 16, 2019, accepted: May 02, 2019, published: May 28, 2019 5.缺点无投稿系统，通过邮箱投稿，无法查询稿件状态，需要通过邮件询问，但是邮件回复的速度很快。不过，目前该杂志已经在着手建立网上投稿系统了，是否可用另一个重要的缺点就是经常要求提交所有的原始数据给杂志社，比较麻烦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541727, encodeId=4f8a541e27d2, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493327, encodeId=3fe449332ef9, content=最好别投这个期刊，现在审稿速度慢，而且要求高，容易拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jan 07 17:02:00 CST 2013, time=2013-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491547, encodeId=743049154e8b, content=听说这个期刊审稿很快。有没有人投稿成功的？分享一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 20 16:28:00 CST 2012, time=2012-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488881, encodeId=8e8d488881b8, content=似乎一年才出一期，20-30篇文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=tjuzhni, createdTime=Tue Jun 12 11:33:00 CST 2012, time=2012-06-12, status=1, ipAttribution=)]

2013-01-07 匿名用户

最好别投这个期刊，现在审稿速度慢，而且要求高，容易拒稿。

422 0

[GetPortalCommentsPageByObjectIdResponse(id=924497, encodeId=285c92449e11, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2018年底投了一篇，1周左右接收，1个月内proof完，接着1个月左右就收录了。不收费。2021年2月再投一篇，结果1周拒了，说是投稿量大，要控制质量，连外审也没送……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDXbgYEwSHiaocLMqOYLBtz9vM1U37Snr4nGLkM2T0V42MoT2hzovDnwNtXw6hdydkhYK3JHnibichHg/0, createdBy=fda41688247, createdName=懒懒的, createdTime=Sat Feb 13 23:29:25 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249235, encodeId=4ec612492356a, content=纯生信收不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b468322691, createdName=ms4000000003909945, createdTime=Thu Sep 15 23:44:27 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101622, encodeId=828411016222f, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101621, encodeId=6968110162159, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590947, encodeId=ef2359094e33, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：***, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590948, encodeId=2e6959094804, content=1.综合性期刊从期刊名就可以看出，该期刊主要收录的研究范围是包括了所有的 experimental 和 clinical 研究的。所以，生物学、医学等生命科学领域的很多文章都可以往这里投。 2.是OA但不收费这种情况是学术界是很少见的，此前还说过一个国产杂志Asian Journal of Pharmaceutical Sciences，也是这样（OA杂志就一定要作者掏钱吗？），但是国产SCI期刊经常会有走后门的文章，一般很难投中。这个杂志似乎更加公平得多。 3.关注者少/竞争小从MedSci投稿经验分享里面可以看出来，其关注人数很少。起的这么诡异的一个期刊名，恐怕是导致其很少被人关注的一个重要原因。 4.审稿快/见刊快一般一审大约2-4周，不拖沓。虽然一年只有一期，但是基本都是接收后很快就上线，紧接着就是WOS收录，并不是等所有文章都准备好了再作为一期统一在线发表。随机查阅几篇今年的文献可以发现，接收的文章一般1-3个月接收，1个月左右发表，赶巧的话，一周内就发表了。 e.g. Received: February 25, 2019, accepted: April 25, 2019, published: May 21, 2019 Received: November 15, 2018, accepted: March 18, 2019, published: March 22, 2019 Received: September 21, 2018, accepted: December 12, 2018, published: January 24, 2019 Received: October 26, 2017, accepted: January 12, 2018, published: January 23, 2019 Received: April 16, 2019, accepted: May 02, 2019, published: May 28, 2019 5.缺点无投稿系统，通过邮箱投稿，无法查询稿件状态，需要通过邮件询问，但是邮件回复的速度很快。不过，目前该杂志已经在着手建立网上投稿系统了，是否可用另一个重要的缺点就是经常要求提交所有的原始数据给杂志社，比较麻烦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541727, encodeId=4f8a541e27d2, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493327, encodeId=3fe449332ef9, content=最好别投这个期刊，现在审稿速度慢，而且要求高，容易拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jan 07 17:02:00 CST 2013, time=2013-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491547, encodeId=743049154e8b, content=听说这个期刊审稿很快。有没有人投稿成功的？分享一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 20 16:28:00 CST 2012, time=2012-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488881, encodeId=8e8d488881b8, content=似乎一年才出一期，20-30篇文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=tjuzhni, createdTime=Tue Jun 12 11:33:00 CST 2012, time=2012-06-12, status=1, ipAttribution=)]

2012-11-20 匿名用户

听说这个期刊审稿很快。有没有人投稿成功的？分享一下吗？

413 0

[GetPortalCommentsPageByObjectIdResponse(id=924497, encodeId=285c92449e11, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：2018年底投了一篇，1周左右接收，1个月内proof完，接着1个月左右就收录了。不收费。2021年2月再投一篇，结果1周拒了，说是投稿量大，要控制质量，连外审也没送……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=171, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDXbgYEwSHiaocLMqOYLBtz9vM1U37Snr4nGLkM2T0V42MoT2hzovDnwNtXw6hdydkhYK3JHnibichHg/0, createdBy=fda41688247, createdName=懒懒的, createdTime=Sat Feb 13 23:29:25 CST 2021, time=2021-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249235, encodeId=4ec612492356a, content=纯生信收不?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b468322691, createdName=ms4000000003909945, createdTime=Thu Sep 15 23:44:27 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101622, encodeId=828411016222f, content=两个IF相当的期刊，如何选择要投哪个？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101621, encodeId=6968110162159, content=老牌期刊和新出版期刊是否都要选一些？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590947, encodeId=ef2359094e33, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：***, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590948, encodeId=2e6959094804, content=1.综合性期刊从期刊名就可以看出，该期刊主要收录的研究范围是包括了所有的 experimental 和 clinical 研究的。所以，生物学、医学等生命科学领域的很多文章都可以往这里投。 2.是OA但不收费这种情况是学术界是很少见的，此前还说过一个国产杂志Asian Journal of Pharmaceutical Sciences，也是这样（OA杂志就一定要作者掏钱吗？），但是国产SCI期刊经常会有走后门的文章，一般很难投中。这个杂志似乎更加公平得多。 3.关注者少/竞争小从MedSci投稿经验分享里面可以看出来，其关注人数很少。起的这么诡异的一个期刊名，恐怕是导致其很少被人关注的一个重要原因。 4.审稿快/见刊快一般一审大约2-4周，不拖沓。虽然一年只有一期，但是基本都是接收后很快就上线，紧接着就是WOS收录，并不是等所有文章都准备好了再作为一期统一在线发表。随机查阅几篇今年的文献可以发现，接收的文章一般1-3个月接收，1个月左右发表，赶巧的话，一周内就发表了。 e.g. Received: February 25, 2019, accepted: April 25, 2019, published: May 21, 2019 Received: November 15, 2018, accepted: March 18, 2019, published: March 22, 2019 Received: September 21, 2018, accepted: December 12, 2018, published: January 24, 2019 Received: October 26, 2017, accepted: January 12, 2018, published: January 23, 2019 Received: April 16, 2019, accepted: May 02, 2019, published: May 28, 2019 5.缺点无投稿系统，通过邮箱投稿，无法查询稿件状态，需要通过邮件询问，但是邮件回复的速度很快。不过，目前该杂志已经在着手建立网上投稿系统了，是否可用另一个重要的缺点就是经常要求提交所有的原始数据给杂志社，比较麻烦。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Fri May 15 00:00:00 CST 2020, time=2020-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541727, encodeId=4f8a541e27d2, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493327, encodeId=3fe449332ef9, content=最好别投这个期刊，现在审稿速度慢，而且要求高，容易拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=422, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Mon Jan 07 17:02:00 CST 2013, time=2013-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=491547, encodeId=743049154e8b, content=听说这个期刊审稿很快。有没有人投稿成功的？分享一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Nov 20 16:28:00 CST 2012, time=2012-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=488881, encodeId=8e8d488881b8, content=似乎一年才出一期，20-30篇文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=tjuzhni, createdTime=Tue Jun 12 11:33:00 CST 2012, time=2012-06-12, status=1, ipAttribution=)]

2012-06-12 tjuzhni

似乎一年才出一期，20-30篇文章

402 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务